Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
- Advertisment -
Tags
Arecor Therapeutics
Tag:
Arecor Therapeutics
Shares
AIM movers: DBAY bids for Alliance Pharma and Enteq shares slide by nearly three-quarters due to delays
Andrew Hore
-
10/01/2025
5
Shares
AIM movers: SDX Energy postpones general meeting and Arecor Therapeutics licence deal
Andrew Hore
-
30/12/2024
0
Shares
AIM movers: Chariot disappoints and Greatland Gold buys back Havieron
Andrew Hore
-
11/09/2024
0
Shares
AIM movers: Kropz falls back from high and Arecor Therapeutics requires cash
Andrew Hore
-
10/06/2024
0
Shares
AIM movers: Nexus Infrastructure order book recovers and Anglo Asian Mining gold production declines
Andrew Hore
-
16/05/2024
2
News
Arecor Therapeutics widens post-tax loss, celebrates diabetes treatment breakthroughs
Natasha Doris
-
25/04/2022
0
IPO Analysis
New AIM admission: Arecor Therapeutics
Andrew Hore
-
03/06/2021
0
Most Read
AIM movers: Trellus Health partners with Johnson & Johnson and Thruvision strategic review
14/01/2025
FTSE 100 ticks marginally higher as housebuilders rise
14/01/2025
Persimmon shares jump as completions rise
14/01/2025
Share Tip: Ramsdens Holdings – record set of Finals see brokers increasing their Target Price to 320p a share, against current 235p on just...
14/01/2025